Total Payments
$48,803
2024 Payments
$898.49
Companies
45
Transactions
668
Medicare Patients
55,464
Medicare Billing
$13.6M
Payment Breakdown by Category
Travel$24,187 (49.6%)
Consulting$11,225 (23.0%)
Food & Beverage$11,000 (22.5%)
Research$2,298 (4.7%)
Education$92.74 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $24,187 | 11 | 49.6% |
| Consulting Fee | $11,225 | 4 | 23.0% |
| Food and Beverage | $11,000 | 638 | 22.5% |
| Unspecified | $2,298 | 1 | 4.7% |
| Education | $92.74 | 14 | 0.2% |
Payments by Type
General
$46,505
667 transactions
Research
$2,298
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ra Medical Systems, Inc. | $39,947 | 134 | $0 (2022) |
| Abbott Laboratories | $955.37 | 52 | $0 (2024) |
| BIOTRONIK INC. | $857.05 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $808.89 | 64 | $0 (2024) |
| Amgen Inc. | $724.42 | 45 | $0 (2024) |
| Boston Scientific Corporation | $625.85 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $519.52 | 23 | $0 (2024) |
| Medtronic, Inc. | $416.50 | 28 | $0 (2024) |
| Amarin Pharma Inc. | $388.49 | 19 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $383.91 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $898.49 | 44 | Merck Sharp & Dohme LLC ($173.88) |
| 2023 | $695.66 | 48 | Medtronic, Inc. ($127.23) |
| 2022 | $6,167 | 65 | Ra Medical Systems, Inc. ($4,800) |
| 2021 | $4,234 | 94 | Ra Medical Systems, Inc. ($3,085) |
| 2020 | $7,064 | 104 | Ra Medical Systems, Inc. ($6,292) |
| 2019 | $25,980 | 132 | Ra Medical Systems, Inc. ($24,802) |
| 2018 | $2,362 | 101 | Ra Medical Systems, Inc. ($968.36) |
| 2017 | $1,403 | 80 | Abbott Laboratories ($311.78) |
All Payment Transactions
668 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: DEVICES | ||||||
| 12/13/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/01/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | Boston Scientific Corporation | VersaCross Access Solution (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: VersaCross Access Solution_ICG | ||||||
| 11/22/2024 | Medtronic, Inc. | CROME DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 11/11/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/24/2024 | Abbott Laboratories | TENDRIL (Device) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: Cardiovascular | ||||||
| 09/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.82 | General |
| 09/13/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Pacemakers | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: Cardiovascular | ||||||
| 08/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/15/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $41.44 | General |
| Category: Coronary | ||||||
| 07/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiology | ||||||
| 07/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Diabetes | ||||||
| 07/04/2024 | CARDIVA MEDICAL, INC. | ESOPHAGEAL COOLING DEVICE (Device) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: DEVICES | ||||||
| 07/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: CARDIOVASCULAR | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RMS-103 | Ra Medical Systems, Inc. | $2,298 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 56 | 18,583 | 42,917 | $9.8M | $4.4M |
| 2022 | 59 | 15,366 | 41,143 | $7.3M | $2.8M |
| 2021 | 65 | 12,881 | 56,460 | $9.6M | $3.7M |
| 2020 | 66 | 8,634 | 40,269 | $6.9M | $2.8M |
Total Patients
55,464
Total Services
180,789
Medicare Billing
$13.6M
Procedure Codes
248
All Medicare Procedures & Services
248 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 1,097 | 1,104 | $2.2M | $1.3M | 60.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 1,098 | 2,210 | $1.3M | $900,587 | 67.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,880 | 4,305 | $809,340 | $432,212 | 53.4% |
| 37229 | Removal of plaque in artery of leg, initial vessel | Office | 2023 | 34 | 37 | $697,783 | $259,873 | 37.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 1,405 | 1,489 | $815,972 | $216,238 | 26.5% |
| 37225 | Removal of plaque in arteries of leg | Office | 2023 | 34 | 39 | $747,591 | $210,275 | 28.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 1,109 | 4,464 | $1.1M | $198,962 | 17.8% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 261 | 264 | $264,000 | $187,204 | 70.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 543 | 566 | $216,778 | $107,997 | 49.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 443 | 456 | $171,912 | $66,646 | 38.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 451 | 473 | $181,159 | $62,838 | 34.7% |
| 37228 | Balloon dilation of artery of leg, initial vessel | Office | 2023 | 14 | 16 | $151,648 | $44,263 | 29.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 173 | 1,655 | $57,960 | $33,257 | 57.4% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 1,086 | 1,093 | $133,346 | $32,716 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 231 | 231 | $66,297 | $30,458 | 45.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,276 | 2,105 | $107,355 | $24,367 | 22.7% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 137 | 240 | $59,040 | $22,400 | 37.9% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 23 | 23 | $34,500 | $18,775 | 54.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 1,087 | 1,094 | $54,700 | $18,543 | 33.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 883 | 1,123 | $41,551 | $14,734 | 35.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 138 | 212 | $28,620 | $13,332 | 46.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 25 | 29 | $34,075 | $12,380 | 36.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 1,087 | 1,094 | $36,089 | $12,209 | 33.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 901 | 1,164 | $33,756 | $12,047 | 35.7% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 58 | 142 | $19,880 | $11,585 | 58.3% |
About Dr. Athar Ansari, M.D
Dr. Athar Ansari, M.D is a Interventional Cardiology healthcare provider based in El Centro, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477612877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Athar Ansari, M.D has received a total of $48,803 in payments from pharmaceutical and medical device companies, with $898.49 received in 2024. These payments were reported across 668 transactions from 45 companies. The most common payment nature is "Travel and Lodging" ($24,187).
As a Medicare-enrolled provider, Ansari has provided services to 55,464 Medicare beneficiaries, totaling 180,789 services with total Medicare billing of $13.6M. Data is available for 4 years (2020–2023), covering 248 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location El Centro, CA
- Active Since 12/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1477612877
Products in Payments
- DABRA (Device) $24,802
- DABRA 101 Catheter (Device) $7,885
- XARELTO (Drug) $803.04
- DABRA laser system (Device) $652.59
- Repatha (Biological) $611.77
- VERQUVO (Drug) $439.61
- Vascepa (Drug) $388.49
- LifeVest (Device) $383.91
- WATCHMAN (Device) $328.35
- DABRA Laser System (Device) $315.77
- Connectivity and Remote care (Device) $308.64
- BYSTOLIC (Drug) $263.32
- BIOMONITOR (Device) $260.17
- ENTRESTO (Drug) $253.09
- COREVALVE EVOLUT R (Device) $225.93
- PRALUENT (Drug) $143.16
- HD-IVUS (Device) $131.24
- DIAMONDBACK PERIPHERAL (Device) $129.90
- ELIQUIS (Drug) $119.32
- Corlanor (Drug) $112.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.